Discover why most women support clinical trials yet rarely get invited, especially among Black women, according to a new ...
Pegtarazimod blocks the C1 complex and the initiators of both the classical and lectin pathways of inflammation. The peptide ...
Matt Pellegrini, a senior operational finance and commercial operations executive, most recently senior director, contract ...
Medicare Part D premiums for standalone drug plans are set to jump sharply in 2027, outpacing Advantage plan cost increases ...
Italian nonprofit Fondazione Telethon and US nonprofit Orphan Therapeutics Accelerator are collaborating to bring curative ...
Boehringer Ingelheim and Microsoft are partnering to build AI-driven digital patient twins that simulate disease progression ...
The firm has closed an oversubscribed Series B, fueling two bold TCR-bispecific programs targeting cancer and autoimmune ...
Alethio Therapeutics has closed an oversubscribed $90 million Series A, providing the capital to advance to clinical stage.
The biotech has raised $25 million to scale its human cell models, targeting industry-standard status as drug discovery ...
Anthropic wants to use AI to address common bottlenecks in clinical trials and says collaborations with B-MS and Enveda – as ...
START and IFO launch a new early-phase cancer trial site in Rome, giving patients access to novel investigational treatments ...
At the end of October, the US Department of Health and Human Services (HHS) announced that it will loosen restrictions around six “gray market” peptide injectables, allowing prescription compounding ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results